Abstract
Oral potentially malignant disorders (OPMDs) are critical precursors to oral cancer, yet clinical detection remains challenging because of substantial phenotypic heterogeneity and overlap with benign conditions. Although image-based deep learning shows promise for automated screening, visual information alone may be insufficient in real-world settings, where diagnostic decisions also rely on patient-specific risk factors. We developed M2-OPMDNet, a multimodal deep learning framework that integrates co-registered white-light and autofluorescence intraoral images with structured clinical information for OPMD detection. A customized questionnaire was designed to capture clinically relevant risk factors and symptoms in a standardized, reproducible format for integration with image-derived features. Multiple image encoders, including conventional convolutional neural networks and foundation model-based architectures, were evaluated using a prospectively collected dataset reflecting real-world screening conditions. Model interpretability was assessed using SHapley Additive exPlanations (SHAP) to quantify feature- and modality-level contributions. M2-OPMDNet achieved an AUC of 0.952, outperforming unimodal approaches and showing improved performance for visually subtle lesions. SHAP analysis demonstrated that structured clinical variables contributed substantially to risk estimation and complemented imaging features. These results demonstrate that explainable multimodal learning combining white-light and autofluorescence imaging with structured clinical data can provide accurate, transparent, and clinically grounded OPMD detection. M2-OPMDNet offers a scalable framework for real-world oral cancer screening and decision support.
Abstract (translated)
URL
https://arxiv.org/abs/2609.04512
